ZSWIM2
gene geneOn this page
Also known as MGC33890ZZZ2MEX
Summary
ZSWIM2 (zinc finger SWIM-type containing 2, HGNC:30990) is a protein-coding gene on chromosome 2q32.1, encoding E3 ubiquitin-protein ligase ZSWIM2 (Q8NEG5). E3 ubiquitin-protein ligase involved in the regulation of Fas-, DR3- and DR4-mediated apoptosis.
Predicted to enable ubiquitin protein ligase activity and zinc ion binding activity. Predicted to be involved in apoptotic process and protein polyubiquitination. Predicted to act upstream of or within positive regulation of extrinsic apoptotic signaling pathway via death domain receptors.
Source: NCBI Gene 151112 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_182521
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30990 |
| Approved symbol | ZSWIM2 |
| Name | zinc finger SWIM-type containing 2 |
| Location | 2q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33890, ZZZ2, MEX |
| Ensembl gene | ENSG00000163012 |
| Ensembl biotype | protein_coding |
| Entrez | 151112 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000295131, ENST00000419862
RefSeq mRNA: 1 — MANE Select: NM_182521
NM_182521
CCDS: CCDS33348
Canonical transcript exons
ENST00000295131 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001070635 | 186827475 | 186828790 |
| ENSE00001070637 | 186833946 | 186834030 |
| ENSE00001070639 | 186848966 | 186849170 |
| ENSE00001070640 | 186833120 | 186833232 |
| ENSE00001070641 | 186838959 | 186839169 |
| ENSE00001070642 | 186829727 | 186829880 |
| ENSE00001130202 | 186837306 | 186837554 |
| ENSE00001241066 | 186844717 | 186844757 |
| ENSE00003506878 | 186847719 | 186847795 |
Expression profiles
Bgee: expression breadth broad, 61 present calls, max score 88.60.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0196 / max 12.6304, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 32793 | 0.0128 | 5 |
| 32794 | 0.0069 | 3 |
Top tissues by expression
222 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.55 | gold quality |
| left testis | UBERON:0004533 | 66.49 | gold quality |
| testis | UBERON:0000473 | 65.92 | gold quality |
| right testis | UBERON:0004534 | 65.19 | gold quality |
| sperm | CL:0000019 | 65.12 | silver quality |
| adenohypophysis | UBERON:0002196 | 56.38 | gold quality |
| pituitary gland | UBERON:0000007 | 55.59 | gold quality |
| buccal mucosa cell | CL:0002336 | 54.37 | silver quality |
| lower lobe of lung | UBERON:0008949 | 50.79 | silver quality |
| prefrontal cortex | UBERON:0000451 | 48.50 | gold quality |
| cortical plate | UBERON:0005343 | 48.33 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 46.22 | gold quality |
| hypothalamus | UBERON:0001898 | 45.69 | gold quality |
| nucleus accumbens | UBERON:0001882 | 45.53 | gold quality |
| cardia of stomach | UBERON:0001162 | 45.46 | gold quality |
| frontal cortex | UBERON:0001870 | 44.50 | gold quality |
| stromal cell of endometrium | CL:0002255 | 44.37 | gold quality |
| neocortex | UBERON:0001950 | 43.85 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| forebrain | UBERON:0001890 | 43.30 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 42.62 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| cerebral cortex | UBERON:0000956 | 42.53 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 42.24 | gold quality |
| right frontal lobe | UBERON:0002810 | 41.95 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| islet of Langerhans | UBERON:0000006 | 41.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
36 targeting ZSWIM2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-6073 | 99.60 | 70.36 | 793 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-6080 | 99.43 | 69.43 | 373 |
| HSA-MIR-3140-5P | 99.39 | 69.04 | 1136 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-5190 | 99.15 | 67.76 | 1234 |
| HSA-MIR-4464 | 98.95 | 67.73 | 820 |
| HSA-MIR-4748 | 98.95 | 67.53 | 810 |
| HSA-MIR-138-2-3P | 98.91 | 68.33 | 1643 |
| HSA-MIR-6074 | 98.89 | 69.64 | 2187 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zswim2 | ENSDARG00000075700 |
| mus_musculus | Zswim2 | ENSMUSG00000034552 |
| rattus_norvegicus | Zswim2 | ENSRNOG00000032579 |
Protein
Protein identifiers
E3 ubiquitin-protein ligase ZSWIM2 — Q8NEG5 (reviewed: Q8NEG5)
Alternative names: MEKK1-related protein X, RING-type E3 ubiquitin transferase ZSWIM2, ZZ-type zinc finger-containing protein 2, Zinc finger SWIM domain-containing protein 2
All UniProt accessions (2): F8WCC6, Q8NEG5
UniProt curated annotations — full annotation on UniProt →
Function. E3 ubiquitin-protein ligase involved in the regulation of Fas-, DR3- and DR4-mediated apoptosis. Functions in conjunction with the UBE2D1, UBE2D3 and UBE2E1 E2 ubiquitin-conjugating enzymes.
Subunit / interactions. Dimer. Interacts with UBE2D1.
Tissue specificity. Expression is testis-specific.
Post-translational modifications. Polyubiquitinated. Polyubiquitination is followed by degradation via the proteasome.
Domain organisation. The SWIM-type zinc finger is required for ubiquitination activity.
RefSeq proteins (1): NP_872327* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000433 | Znf_ZZ | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR007527 | Znf_SWIM | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR039903 | Zswim2 | Family |
| IPR043145 | Znf_ZZ_sf | Homologous_superfamily |
Pfam: PF00569, PF04434, PF13639
UniProt features (27 total): binding site 8, sequence conflict 7, strand 5, zinc finger region 4, helix 2, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2DIP | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEG5-F1 | 63.82 | 0.36 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 261; 267; 270; 234; 237; 249; 252; 258
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 57 (showing top):
GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS, GOBP_APOPTOTIC_SIGNALING_PATHWAY, GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_PROTEIN_POLYUBIQUITINATION, MYB_Q3, GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS, GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY, MYB_Q5_01, GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY
GO Biological Process (3): protein polyubiquitination (GO:0000209), apoptotic process (GO:0006915), positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)
GO Molecular Function (5): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), ubiquitin-protein transferase activity (GO:0004842), transferase activity (GO:0016740), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein ubiquitination | 1 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| extrinsic apoptotic signaling pathway via death domain receptors | 1 |
| regulation of extrinsic apoptotic signaling pathway via death domain receptors | 1 |
| positive regulation of extrinsic apoptotic signaling pathway | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| ubiquitin-like protein transferase activity | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
508 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZSWIM2 | TSNAXIP1 | Q2TAA8 | 563 |
| ZSWIM2 | RSPH14 | Q9UHP6 | 535 |
| ZSWIM2 | OXNAD1 | Q96HP4 | 534 |
| ZSWIM2 | CCDC146 | Q8IYE0 | 517 |
| ZSWIM2 | CFAP74 | Q9C0B2 | 500 |
| ZSWIM2 | RSPH10B | P0C881 | 497 |
| ZSWIM2 | CFAP52 | Q8N1V2 | 466 |
| ZSWIM2 | ZZZ3 | Q8IYH5 | 458 |
| ZSWIM2 | LRRC34 | Q8IZ02 | 457 |
| ZSWIM2 | EBNA1BP2 | Q99848 | 457 |
| ZSWIM2 | LRRC23 | Q53EV4 | 453 |
| ZSWIM2 | SLC66A1 | Q6ZP29 | 451 |
| ZSWIM2 | CFAP161 | Q6P656 | 449 |
| ZSWIM2 | SAXO2 | Q658L1 | 425 |
| ZSWIM2 | CFAP57 | Q96MR6 | 425 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZSWIM2 | SEMG1 | psi-mi:“MI:0914”(association) | 0.530 |
| ZSWIM2 | EZR | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZSWIM2 | UBE2U | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | ZSWIM2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MAGEA11 | ZSWIM2 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (17): ZSWIM2 (Two-hybrid), BCAM (Affinity Capture-MS), TKTL2 (Affinity Capture-MS), SEMG1 (Affinity Capture-MS), LRFN4 (Affinity Capture-MS), RNASE7 (Affinity Capture-MS), ZSWIM2 (Synthetic Lethality), ZSWIM2 (Proximity Label-MS), TKTL2 (Affinity Capture-MS), LRFN4 (Affinity Capture-MS), BCAM (Affinity Capture-MS), RNASE7 (Affinity Capture-MS), SEMG1 (Affinity Capture-MS), ZSWIM2 (Positive Genetic), ZSWIM2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1L8HU22, C0SV12, C0SVM5, F4I443, O22199, O22800, O23379, O50055, O65312, O82256, O82617, P0CB22, Q0IGM7, Q0P4S5, Q1G3I2, Q1G3Q4, Q39057, Q6EU49, Q6NPP4, Q6NQ79, Q6ZJM9, Q8BZ05, Q8GZ42, Q8NEG5, Q8WZ64, Q940T9, Q946J2, Q96288, Q96502, Q9C5X4, Q9C7E8, Q9C9F4, Q9D9X6, Q9FHH8, Q9FNC7, Q9FZ36, Q9LDT3, Q9LJ44, Q9LRM4, Q9LUA9
Diamond homologs: A2CI97, A2CI98, A2CJ06, G3V7L1, O97592, P11530, P11531, P11532, P11533, P46939, Q05AA6, Q0KI50, Q13474, Q5GN48, Q7YU29, Q8NEG5, Q9EPA0, Q9TW65, Q9VDW3, Q9VDW6, Q9Y4J8, A5WWA0, E9QAU8, F4HZZ4, F4HZZ5, F4I2Y3, O22755, O43567, O64762, O82353, P0C034, P0DPR2, P87119, Q07G42, Q08CG8, Q08D68, Q08DI6, Q0II22, Q0V9R0, Q0VD51
SIGNOR signaling
5 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | ZSWIM2 | ubiquitination |
| UBE2D1 | “up-regulates activity” | ZSWIM2 | binding |
| UBE2E1 | “up-regulates activity” | ZSWIM2 | binding |
| ZSWIM2 | up-regulates | Apoptosis | |
| UBE2D3 | “up-regulates activity” | ZSWIM2 | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1138 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:186829876:CTTGG:C | acceptor_gain | 1.0000 |
| 2:186833118:AC:A | donor_gain | 1.0000 |
| 2:186833119:CC:C | donor_gain | 1.0000 |
| 2:186837304:A:AC | donor_gain | 1.0000 |
| 2:186837305:C:CT | donor_gain | 1.0000 |
| 2:186837317:C:A | donor_gain | 1.0000 |
| 2:186839167:CAG:C | acceptor_gain | 1.0000 |
| 2:186839170:C:CC | acceptor_gain | 1.0000 |
| 2:186848964:A:AC | donor_gain | 1.0000 |
| 2:186848965:C:CC | donor_gain | 1.0000 |
| 2:186848965:CT:C | donor_gain | 1.0000 |
| 2:186828791:C:CC | acceptor_gain | 0.9900 |
| 2:186828792:T:C | acceptor_gain | 0.9900 |
| 2:186829881:C:CC | acceptor_gain | 0.9900 |
| 2:186837316:T:TA | donor_gain | 0.9900 |
| 2:186837344:A:AC | donor_gain | 0.9900 |
| 2:186838954:ATCAC:A | donor_loss | 0.9900 |
| 2:186838955:TCA:T | donor_loss | 0.9900 |
| 2:186838956:CAC:C | donor_loss | 0.9900 |
| 2:186838957:A:T | donor_loss | 0.9900 |
| 2:186839165:AGCAG:A | acceptor_gain | 0.9900 |
| 2:186839166:GCAG:G | acceptor_gain | 0.9900 |
| 2:186839167:CAGC:C | acceptor_gain | 0.9900 |
| 2:186839168:AG:A | acceptor_gain | 0.9900 |
| 2:186839169:GCTAG:G | acceptor_loss | 0.9900 |
| 2:186839171:T:G | acceptor_loss | 0.9900 |
| 2:186847712:CACT:C | donor_loss | 0.9900 |
| 2:186847716:T:TC | donor_loss | 0.9900 |
| 2:186847717:A:AC | donor_gain | 0.9900 |
| 2:186847718:C:CC | donor_gain | 0.9900 |
AlphaMissense
4208 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:186837469:A:G | C194R | 0.991 |
| 2:186839014:A:G | C147R | 0.986 |
| 2:186828788:A:C | F366L | 0.985 |
| 2:186828788:A:T | F366L | 0.985 |
| 2:186828790:A:G | F366L | 0.985 |
| 2:186838963:A:G | C164R | 0.984 |
| 2:186829792:A:G | C344R | 0.983 |
| 2:186833950:C:G | R275P | 0.981 |
| 2:186837523:A:G | C176R | 0.981 |
| 2:186837468:C:G | C194S | 0.980 |
| 2:186837469:A:T | C194S | 0.980 |
| 2:186849005:G:C | F42L | 0.980 |
| 2:186849005:G:T | F42L | 0.980 |
| 2:186849007:A:G | F42L | 0.980 |
| 2:186829791:C:G | C344S | 0.979 |
| 2:186829792:A:T | C344S | 0.979 |
| 2:186837349:A:G | C234R | 0.978 |
| 2:186838962:C:G | C164S | 0.976 |
| 2:186838963:A:T | C164S | 0.976 |
| 2:186839012:G:C | C147W | 0.976 |
| 2:186837522:C:G | C176S | 0.975 |
| 2:186837523:A:T | C176S | 0.975 |
| 2:186839005:A:G | C150R | 0.975 |
| 2:186833217:A:G | W282R | 0.974 |
| 2:186833217:A:T | W282R | 0.974 |
| 2:186838961:G:C | C164W | 0.973 |
| 2:186828742:A:G | C382R | 0.972 |
| 2:186837446:A:C | F201L | 0.971 |
| 2:186837446:A:T | F201L | 0.971 |
| 2:186837448:A:G | F201L | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000003166 (2:186849048 C>G), RS1000303248 (2:186830264 C>T), RS1000353435 (2:186830117 G>A,T), RS1000579638 (2:186850313 A>C), RS1000729022 (2:186831203 T>C), RS1000739157 (2:186828767 G>A), RS1000900157 (2:186834382 G>A), RS1001000816 (2:186840657 A>T), RS1001045485 (2:186840352 A>G), RS1001088173 (2:186829063 T>C), RS1001230098 (2:186832965 C>A,G,T), RS1001283041 (2:186834398 G>T), RS1001335669 (2:186834617 C>A), RS1001552861 (2:186846016 T>G), RS1001581002 (2:186840856 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006624_75 | Systolic blood pressure | 1.000000e-11 |
| GCST90020025_1718 | Waist-to-hip ratio adjusted for BMI | 3.000000e-08 |
| GCST90020026_371 | Hip index | 2.000000e-09 |
| GCST90020029_844 | Waist circumference adjusted for body mass index | 4.000000e-08 |
| GCST90020029_845 | Waist circumference adjusted for body mass index | 1.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| semilicoisoflavone B | decreases phosphorylation | 1 |
| Arsenic | increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Lead | affects methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.